Search results
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 2 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 23 hours agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 4 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
...Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 ...
NewMediaWire via Yahoo Finance· 3 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 7 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 7 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 7 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via AOL· 7 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...